Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment Article Swipe
Soo Chin Lee
,
Yeon Hee Park
,
Christian F. Singer
,
Judith Balmaña
,
Rebecca Dent
,
Veronique Kiak‐Mien Tan
,
Nadia Ayu Mulansari
,
Mastura Md Yusof
,
Frances Victoria Que
,
Yen‐Shen Lu
,
Napa Parinyanitikul
,
Cẩm Phương Phạm
,
Nur Aishah Mohd Taib
,
Sun-Young Kong
,
Yoland Antill
,
Hee Jeong Kim
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3389/fonc.2025.1507836
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3389/fonc.2025.1507836
Introduction In the Asia-Pacific region, there is increasing contention on the practical challenges involved in managing human epidermal growth factor receptor 2 (HER2)-negative early breast cancer (eBC). This modified Delphi consensus explores gaps in genetic counselling (GC) and genetic testing (GT), and clinical risk assessment for HER2 -negative eBC. Methods An expert panel of 16 Asia-Pacific medical oncologists, geneticists, and breast cancer surgeons arrived at 33 statements. The level of statement consensus was considered high at ≥75%. A survey of 134 healthcare practitioners (HCPs) (breast cancer surgeons, geneticists, oncologists, molecular biologists/pathologists) explored the real-world practices in this region. Results A consensus was reached for 88% of the statements (29/33) and aligned with international guidelines. Experts reached 100% consensus on offering pretest GC, obtaining consent before GT, considering first diagnosis of breast cancer (BC) as ideal time for GT, offering reflex testing for patients with likely/pathogenic germline BRCA variant, and considering patients with germline BRCA mutant early triple-negative breast cancer (TNBC) patients who do not achieve pathological complete response after neoadjuvant treatment to be at high risk of recurrence. Over 90% of experts supported germline GT for BRCA for TNBC patients irrespective of age at diagnosis or family history and prioritised tumour size and nodal status as prognostic factors for cancer recurrence. Experts reached 80%-90% consensus for using genetic risk assessment tools in low/under-resourced healthcare systems and considering patients with likely/pathogenic variants in BRCA for risk reduction surgery. Significant gaps existed between real-world practices and recommendations, particularly in offering pretest GC to patients with suspected hereditary BC and to blood relatives of patients with BRCA germline pathogenic variant BC, ideal time for GT, considering GT for early TNBC patients irrespective of age, offering post-test GC for positive results, utilising risk assessment tools, and streamlining GC through non-geneticist HCPs. Conclusion GT and pretest GC should be mainstreamed at the first diagnosis of BC. Risk assessment for disease recurrence should be performed at diagnosis and post-surgery for HER2 -negative eBC patients. These recommendations would help standardise GC and improve GT access for clinical decisions.
Related Topics
Concepts
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.3389/fonc.2025.1507836
- https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1507836/pdf
- OA Status
- gold
- References
- 38
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4411531782
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4411531782Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3389/fonc.2025.1507836Digital Object Identifier
- Title
-
Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessmentWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-06-23Full publication date if available
- Authors
-
Soo Chin Lee, Yeon Hee Park, Christian F. Singer, Judith Balmaña, Rebecca Dent, Veronique Kiak‐Mien Tan, Nadia Ayu Mulansari, Mastura Md Yusof, Frances Victoria Que, Yen‐Shen Lu, Napa Parinyanitikul, Cẩm Phương Phạm, Nur Aishah Mohd Taib, Sun-Young Kong, Yoland Antill, Hee Jeong KimList of authors in order
- Landing page
-
https://doi.org/10.3389/fonc.2025.1507836Publisher landing page
- PDF URL
-
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1507836/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1507836/pdfDirect OA link when available
- Concepts
-
Breast cancer, Medicine, Cancer, Risk assessment, Consensus conference, Oncology, Family medicine, Internal medicine, Computer science, Computer securityTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
38Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4411531782 |
|---|---|
| doi | https://doi.org/10.3389/fonc.2025.1507836 |
| ids.doi | https://doi.org/10.3389/fonc.2025.1507836 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40626014 |
| ids.openalex | https://openalex.org/W4411531782 |
| fwci | 0.0 |
| type | review |
| title | Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment |
| biblio.issue | |
| biblio.volume | 15 |
| biblio.last_page | 1507836 |
| biblio.first_page | 1507836 |
| topics[0].id | https://openalex.org/T10183 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9991999864578247 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1306 |
| topics[0].subfield.display_name | Cancer Research |
| topics[0].display_name | Breast Cancer Treatment Studies |
| topics[1].id | https://openalex.org/T10755 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9966999888420105 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | HER2/EGFR in Cancer Research |
| topics[2].id | https://openalex.org/T12829 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9958000183105469 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Advanced Breast Cancer Therapies |
| funders[0].id | https://openalex.org/F4320307770 |
| funders[0].ror | https://ror.org/04r9x1a08 |
| funders[0].display_name | AstraZeneca |
| is_xpac | False |
| apc_list.value | 2950 |
| apc_list.currency | USD |
| apc_list.value_usd | 2950 |
| apc_paid.value | 2950 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2950 |
| concepts[0].id | https://openalex.org/C530470458 |
| concepts[0].level | 3 |
| concepts[0].score | 0.6327288150787354 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[0].display_name | Breast cancer |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.6054853796958923 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C121608353 |
| concepts[2].level | 2 |
| concepts[2].score | 0.4377763271331787 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[2].display_name | Cancer |
| concepts[3].id | https://openalex.org/C12174686 |
| concepts[3].level | 2 |
| concepts[3].score | 0.41877442598342896 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1058438 |
| concepts[3].display_name | Risk assessment |
| concepts[4].id | https://openalex.org/C3017605391 |
| concepts[4].level | 2 |
| concepts[4].score | 0.41640979051589966 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1021509 |
| concepts[4].display_name | Consensus conference |
| concepts[5].id | https://openalex.org/C143998085 |
| concepts[5].level | 1 |
| concepts[5].score | 0.37719136476516724 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[5].display_name | Oncology |
| concepts[6].id | https://openalex.org/C512399662 |
| concepts[6].level | 1 |
| concepts[6].score | 0.33662551641464233 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[6].display_name | Family medicine |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.2641110420227051 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| concepts[8].id | https://openalex.org/C41008148 |
| concepts[8].level | 0 |
| concepts[8].score | 0.14942008256912231 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[8].display_name | Computer science |
| concepts[9].id | https://openalex.org/C38652104 |
| concepts[9].level | 1 |
| concepts[9].score | 0.08634257316589355 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q3510521 |
| concepts[9].display_name | Computer security |
| keywords[0].id | https://openalex.org/keywords/breast-cancer |
| keywords[0].score | 0.6327288150787354 |
| keywords[0].display_name | Breast cancer |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.6054853796958923 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/cancer |
| keywords[2].score | 0.4377763271331787 |
| keywords[2].display_name | Cancer |
| keywords[3].id | https://openalex.org/keywords/risk-assessment |
| keywords[3].score | 0.41877442598342896 |
| keywords[3].display_name | Risk assessment |
| keywords[4].id | https://openalex.org/keywords/consensus-conference |
| keywords[4].score | 0.41640979051589966 |
| keywords[4].display_name | Consensus conference |
| keywords[5].id | https://openalex.org/keywords/oncology |
| keywords[5].score | 0.37719136476516724 |
| keywords[5].display_name | Oncology |
| keywords[6].id | https://openalex.org/keywords/family-medicine |
| keywords[6].score | 0.33662551641464233 |
| keywords[6].display_name | Family medicine |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.2641110420227051 |
| keywords[7].display_name | Internal medicine |
| keywords[8].id | https://openalex.org/keywords/computer-science |
| keywords[8].score | 0.14942008256912231 |
| keywords[8].display_name | Computer science |
| keywords[9].id | https://openalex.org/keywords/computer-security |
| keywords[9].score | 0.08634257316589355 |
| keywords[9].display_name | Computer security |
| language | en |
| locations[0].id | doi:10.3389/fonc.2025.1507836 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2596394214 |
| locations[0].source.issn | 2234-943X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2234-943X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Frontiers in Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_name | Frontiers Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_lineage_names | Frontiers Media |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1507836/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Frontiers in Oncology |
| locations[0].landing_page_url | https://doi.org/10.3389/fonc.2025.1507836 |
| locations[1].id | pmid:40626014 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Frontiers in oncology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40626014 |
| locations[2].id | pmh:oai:doaj.org/article:24833b45558245aead46d8e895f1791d |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Frontiers in Oncology, Vol 15 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/24833b45558245aead46d8e895f1791d |
| locations[3].id | pmh:oai:europepmc.org:11038478 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400806 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Europe PMC (PubMed Central) |
| locations[3].source.host_organization | https://openalex.org/I1303153112 |
| locations[3].source.host_organization_name | European Bioinformatics Institute |
| locations[3].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12230085 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5033700679 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-5835-6419 |
| authorships[0].author.display_name | Soo Chin Lee |
| authorships[0].countries | SG |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210103786 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore |
| authorships[0].institutions[0].id | https://openalex.org/I4210103786 |
| authorships[0].institutions[0].ror | https://ror.org/025yypj46 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210103786, https://openalex.org/I4210150261 |
| authorships[0].institutions[0].country_code | SG |
| authorships[0].institutions[0].display_name | National University Cancer Institute, Singapore |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Soo Chin Lee |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore |
| authorships[1].author.id | https://openalex.org/A5101445353 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-4156-9212 |
| authorships[1].author.display_name | Yeon Hee Park |
| authorships[1].countries | KR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2802194831, https://openalex.org/I848706 |
| authorships[1].affiliations[0].raw_affiliation_string | Division of Haematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea |
| authorships[1].institutions[0].id | https://openalex.org/I2802194831 |
| authorships[1].institutions[0].ror | https://ror.org/05a15z872 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I2250650973, https://openalex.org/I2802194831 |
| authorships[1].institutions[0].country_code | KR |
| authorships[1].institutions[0].display_name | Samsung Medical Center |
| authorships[1].institutions[1].id | https://openalex.org/I848706 |
| authorships[1].institutions[1].ror | https://ror.org/04q78tk20 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I848706 |
| authorships[1].institutions[1].country_code | KR |
| authorships[1].institutions[1].display_name | Sungkyunkwan University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Yeon Hee Park |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Division of Haematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea |
| authorships[2].author.id | https://openalex.org/A5114240317 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Christian F. Singer |
| authorships[2].countries | AT |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210092129, https://openalex.org/I76134821 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Obstetrics and Gynaecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria |
| authorships[2].institutions[0].id | https://openalex.org/I4210092129 |
| authorships[2].institutions[0].ror | https://ror.org/00df3z122 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I2802328216, https://openalex.org/I4210092129 |
| authorships[2].institutions[0].country_code | AT |
| authorships[2].institutions[0].display_name | Comprehensive Cancer Center Vienna |
| authorships[2].institutions[1].id | https://openalex.org/I76134821 |
| authorships[2].institutions[1].ror | https://ror.org/05n3x4p02 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I76134821 |
| authorships[2].institutions[1].country_code | AT |
| authorships[2].institutions[1].display_name | Medical University of Vienna |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Christian F. Singer |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Obstetrics and Gynaecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria |
| authorships[3].author.id | https://openalex.org/A5107913771 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Judith Balmaña |
| authorships[3].countries | ES |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210127641 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Medical Oncology, University Hospital Campus Vall Hebron, Barcelona, Spain |
| authorships[3].institutions[0].id | https://openalex.org/I4210127641 |
| authorships[3].institutions[0].ror | https://ror.org/03ba28x55 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210127641 |
| authorships[3].institutions[0].country_code | ES |
| authorships[3].institutions[0].display_name | Vall d'Hebron Hospital Universitari |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Judith Balmaña |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Medical Oncology, University Hospital Campus Vall Hebron, Barcelona, Spain |
| authorships[4].author.id | https://openalex.org/A5056387446 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-6421-7602 |
| authorships[4].author.display_name | Rebecca Dent |
| authorships[4].countries | SG |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210137145 |
| authorships[4].affiliations[0].raw_affiliation_string | Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore |
| authorships[4].institutions[0].id | https://openalex.org/I4210137145 |
| authorships[4].institutions[0].ror | https://ror.org/03bqk3e80 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210137145 |
| authorships[4].institutions[0].country_code | SG |
| authorships[4].institutions[0].display_name | National Cancer Centre Singapore |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Rebecca Alexandra Dent |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore |
| authorships[5].author.id | https://openalex.org/A5103968411 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Veronique Kiak‐Mien Tan |
| authorships[5].countries | SG |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210137145 |
| authorships[5].affiliations[0].raw_affiliation_string | Division of Surgery and Surgical Oncology, Department of Breast Surgery, National Cancer Centre Singapore, Singapore, Singapore |
| authorships[5].institutions[0].id | https://openalex.org/I4210137145 |
| authorships[5].institutions[0].ror | https://ror.org/03bqk3e80 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210137145 |
| authorships[5].institutions[0].country_code | SG |
| authorships[5].institutions[0].display_name | National Cancer Centre Singapore |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Veronique Kiak-Mien Tan |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Division of Surgery and Surgical Oncology, Department of Breast Surgery, National Cancer Centre Singapore, Singapore, Singapore |
| authorships[6].author.id | https://openalex.org/A5045111523 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-2242-7641 |
| authorships[6].author.display_name | Nadia Ayu Mulansari |
| authorships[6].countries | ID |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I29617571, https://openalex.org/I4210155152 |
| authorships[6].affiliations[0].raw_affiliation_string | Haematology-Medical Oncology Division, Internal Medicine Department, Cipto Mangunkusumo National General Hospital/Universitas Indonesia, Jakarta, Indonesia |
| authorships[6].institutions[0].id | https://openalex.org/I4210155152 |
| authorships[6].institutions[0].ror | https://ror.org/05am7x020 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210155152 |
| authorships[6].institutions[0].country_code | ID |
| authorships[6].institutions[0].display_name | Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo |
| authorships[6].institutions[1].id | https://openalex.org/I29617571 |
| authorships[6].institutions[1].ror | https://ror.org/0116zj450 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I29617571 |
| authorships[6].institutions[1].country_code | ID |
| authorships[6].institutions[1].display_name | University of Indonesia |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Nadia Ayu Mulansari |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Haematology-Medical Oncology Division, Internal Medicine Department, Cipto Mangunkusumo National General Hospital/Universitas Indonesia, Jakarta, Indonesia |
| authorships[7].author.id | https://openalex.org/A5038885313 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-8634-0468 |
| authorships[7].author.display_name | Mastura Md Yusof |
| authorships[7].countries | MY |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210092640 |
| authorships[7].affiliations[0].raw_affiliation_string | Picaso Cancer Centre, Hospital Picaso, Petaling Jaya, Selangor, Malaysia |
| authorships[7].institutions[0].id | https://openalex.org/I4210092640 |
| authorships[7].institutions[0].ror | https://ror.org/00g0aq541 |
| authorships[7].institutions[0].type | nonprofit |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210092640, https://openalex.org/I4210147568 |
| authorships[7].institutions[0].country_code | MY |
| authorships[7].institutions[0].display_name | Cancer Research Malaysia |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Mastura Md Yusof |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Picaso Cancer Centre, Hospital Picaso, Petaling Jaya, Selangor, Malaysia |
| authorships[8].author.id | https://openalex.org/A5004930087 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-7341-4392 |
| authorships[8].author.display_name | Frances Victoria Que |
| authorships[8].countries | PH |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210116402 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Internal Medicine and Oncology, St Luke's Medical Center, Quezon City and Global City, Metro Manila, Philippines |
| authorships[8].institutions[0].id | https://openalex.org/I4210116402 |
| authorships[8].institutions[0].ror | https://ror.org/02h4kdd20 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210116402 |
| authorships[8].institutions[0].country_code | PH |
| authorships[8].institutions[0].display_name | St. Luke's Medical Center |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Frances Victoria F. Que |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Internal Medicine and Oncology, St Luke's Medical Center, Quezon City and Global City, Metro Manila, Philippines |
| authorships[9].author.id | https://openalex.org/A5009846821 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-7461-1291 |
| authorships[9].author.display_name | Yen‐Shen Lu |
| authorships[9].countries | TW |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210131804 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan |
| authorships[9].institutions[0].id | https://openalex.org/I4210131804 |
| authorships[9].institutions[0].ror | https://ror.org/03nteze27 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210131804 |
| authorships[9].institutions[0].country_code | TW |
| authorships[9].institutions[0].display_name | National Taiwan University Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Yen-Shen Lu |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan |
| authorships[10].author.id | https://openalex.org/A5000925709 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-3701-5663 |
| authorships[10].author.display_name | Napa Parinyanitikul |
| authorships[10].countries | TH |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I2802209374 |
| authorships[10].affiliations[0].raw_affiliation_string | Medical Oncology Unit, King Chulalongkorn Memorial Hospital, Bangkok, Thailand |
| authorships[10].institutions[0].id | https://openalex.org/I2802209374 |
| authorships[10].institutions[0].ror | https://ror.org/05jd2pj53 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I2802209374 |
| authorships[10].institutions[0].country_code | TH |
| authorships[10].institutions[0].display_name | King Chulalongkorn Memorial Hospital |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Napa Parinyanitikul |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Medical Oncology Unit, King Chulalongkorn Memorial Hospital, Bangkok, Thailand |
| authorships[11].author.id | https://openalex.org/A5103850941 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-4342-0959 |
| authorships[11].author.display_name | Cẩm Phương Phạm |
| authorships[11].countries | VN |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210152634 |
| authorships[11].affiliations[0].raw_affiliation_string | Nuclear Medicine and Oncology Center, Bach Mai Hospital, Hanoi, Vietnam |
| authorships[11].institutions[0].id | https://openalex.org/I4210152634 |
| authorships[11].institutions[0].ror | https://ror.org/05ecec111 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210152634 |
| authorships[11].institutions[0].country_code | VN |
| authorships[11].institutions[0].display_name | Bạch Mai Hospital |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Cam Phuong Pham |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Nuclear Medicine and Oncology Center, Bach Mai Hospital, Hanoi, Vietnam |
| authorships[12].author.id | https://openalex.org/A5087872892 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-8419-0478 |
| authorships[12].author.display_name | Nur Aishah Mohd Taib |
| authorships[12].affiliations[0].raw_affiliation_string | Department of Surgery, Faculty of Medicine, University Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia |
| authorships[12].affiliations[1].raw_affiliation_string | Department of Surgery, Faculty of Medicine, University Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia. |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Nur Aishah Taib |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Department of Surgery, Faculty of Medicine, University Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia, Department of Surgery, Faculty of Medicine, University Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia. |
| authorships[13].author.id | https://openalex.org/A5113885259 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Sun-Young Kong |
| authorships[13].countries | KR |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210120052 |
| authorships[13].affiliations[0].raw_affiliation_string | Department of Laboratory Medicine and Genetic Counselling Clinic, National Cancer Center, Goyang, Republic of Korea |
| authorships[13].institutions[0].id | https://openalex.org/I4210120052 |
| authorships[13].institutions[0].ror | https://ror.org/02tsanh21 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I1290491151, https://openalex.org/I2801339556, https://openalex.org/I4210120052 |
| authorships[13].institutions[0].country_code | KR |
| authorships[13].institutions[0].display_name | National Cancer Center |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Sun-Young Kong |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Department of Laboratory Medicine and Genetic Counselling Clinic, National Cancer Center, Goyang, Republic of Korea |
| authorships[14].author.id | https://openalex.org/A5035050460 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-6366-5523 |
| authorships[14].author.display_name | Yoland Antill |
| authorships[14].countries | AU |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I1320473756 |
| authorships[14].affiliations[0].raw_affiliation_string | Familial Cancer Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia |
| authorships[14].affiliations[1].institution_ids | https://openalex.org/I56590836 |
| authorships[14].affiliations[1].raw_affiliation_string | Faculty of Medicine and Health Sciences, Monash University, Melbourne, VIC, Australia |
| authorships[14].institutions[0].id | https://openalex.org/I56590836 |
| authorships[14].institutions[0].ror | https://ror.org/02bfwt286 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I56590836 |
| authorships[14].institutions[0].country_code | AU |
| authorships[14].institutions[0].display_name | Monash University |
| authorships[14].institutions[1].id | https://openalex.org/I1320473756 |
| authorships[14].institutions[1].ror | https://ror.org/005bvs909 |
| authorships[14].institutions[1].type | healthcare |
| authorships[14].institutions[1].lineage | https://openalex.org/I1320473756, https://openalex.org/I4210158168 |
| authorships[14].institutions[1].country_code | AU |
| authorships[14].institutions[1].display_name | The Royal Melbourne Hospital |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Yoland Antill |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Faculty of Medicine and Health Sciences, Monash University, Melbourne, VIC, Australia, Familial Cancer Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia |
| authorships[15].author.id | https://openalex.org/A5052099934 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-4509-953X |
| authorships[15].author.display_name | Hee Jeong Kim |
| authorships[15].countries | KR |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I116631150, https://openalex.org/I2801680663, https://openalex.org/I40542001 |
| authorships[15].affiliations[0].raw_affiliation_string | Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea |
| authorships[15].institutions[0].id | https://openalex.org/I2801680663 |
| authorships[15].institutions[0].ror | https://ror.org/03s5q0090 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I2801680663, https://openalex.org/I4210167194 |
| authorships[15].institutions[0].country_code | KR |
| authorships[15].institutions[0].display_name | Asan Medical Center |
| authorships[15].institutions[1].id | https://openalex.org/I116631150 |
| authorships[15].institutions[1].ror | https://ror.org/02tec3785 |
| authorships[15].institutions[1].type | education |
| authorships[15].institutions[1].lineage | https://openalex.org/I116631150 |
| authorships[15].institutions[1].country_code | KR |
| authorships[15].institutions[1].display_name | Ulsan College |
| authorships[15].institutions[2].id | https://openalex.org/I40542001 |
| authorships[15].institutions[2].ror | https://ror.org/02c2f8975 |
| authorships[15].institutions[2].type | education |
| authorships[15].institutions[2].lineage | https://openalex.org/I40542001 |
| authorships[15].institutions[2].country_code | KR |
| authorships[15].institutions[2].display_name | University of Ulsan |
| authorships[15].author_position | last |
| authorships[15].raw_author_name | Hee Jeong Kim |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1507836/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-06-23T00:00:00 |
| display_name | Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10183 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9991999864578247 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1306 |
| primary_topic.subfield.display_name | Cancer Research |
| primary_topic.display_name | Breast Cancer Treatment Studies |
| related_works | https://openalex.org/W4391375266, https://openalex.org/W1989380599, https://openalex.org/W4405112912, https://openalex.org/W2375584271, https://openalex.org/W1997105855, https://openalex.org/W4301030387, https://openalex.org/W2414286769, https://openalex.org/W2013223288, https://openalex.org/W3015743358, https://openalex.org/W2892677547 |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.3389/fonc.2025.1507836 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2596394214 |
| best_oa_location.source.issn | 2234-943X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2234-943X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Frontiers in Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_name | Frontiers Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_lineage_names | Frontiers Media |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1507836/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Frontiers in Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.3389/fonc.2025.1507836 |
| primary_location.id | doi:10.3389/fonc.2025.1507836 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2596394214 |
| primary_location.source.issn | 2234-943X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2234-943X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Frontiers in Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_name | Frontiers Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_lineage_names | Frontiers Media |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1507836/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Frontiers in Oncology |
| primary_location.landing_page_url | https://doi.org/10.3389/fonc.2025.1507836 |
| publication_date | 2025-06-23 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4293776972, https://openalex.org/W4293237398, https://openalex.org/W3128646645, https://openalex.org/W2123618524, https://openalex.org/W3019618086, https://openalex.org/W2045945682, https://openalex.org/W3000643213, https://openalex.org/W3209654964, https://openalex.org/W3124119591, https://openalex.org/W4206632106, https://openalex.org/W3100475287, https://openalex.org/W1949432070, https://openalex.org/W3134914296, https://openalex.org/W3038757962, https://openalex.org/W4225102720, https://openalex.org/W2904268248, https://openalex.org/W2885648482, https://openalex.org/W2963845618, https://openalex.org/W4206317767, https://openalex.org/W2165010366, https://openalex.org/W2414241833, https://openalex.org/W4390575634, https://openalex.org/W3118983547, https://openalex.org/W3011823578, https://openalex.org/W2958679308, https://openalex.org/W3165576985, https://openalex.org/W4304084160, https://openalex.org/W3128456160, https://openalex.org/W4362693994, https://openalex.org/W2258156433, https://openalex.org/W4200437485, https://openalex.org/W2892752169, https://openalex.org/W4392554015, https://openalex.org/W4244203290, https://openalex.org/W3022758966, https://openalex.org/W2944938025, https://openalex.org/W4281560766, https://openalex.org/W4223622943 |
| referenced_works_count | 38 |
| abstract_inverted_index.2 | 21 |
| abstract_inverted_index.A | 77, 99 |
| abstract_inverted_index.16 | 54 |
| abstract_inverted_index.33 | 65 |
| abstract_inverted_index.An | 50 |
| abstract_inverted_index.BC | 255 |
| abstract_inverted_index.GC | 249, 283, 293, 301, 333 |
| abstract_inverted_index.GT | 184, 273, 298, 336 |
| abstract_inverted_index.In | 1 |
| abstract_inverted_index.as | 133, 205 |
| abstract_inverted_index.at | 64, 75, 173, 193, 305, 319 |
| abstract_inverted_index.be | 172, 303, 317 |
| abstract_inverted_index.do | 162 |
| abstract_inverted_index.in | 14, 33, 95, 221, 231, 246 |
| abstract_inverted_index.is | 6 |
| abstract_inverted_index.of | 53, 69, 79, 105, 129, 176, 180, 191, 260, 279, 309 |
| abstract_inverted_index.on | 9, 118 |
| abstract_inverted_index.or | 195 |
| abstract_inverted_index.to | 171, 250, 257 |
| abstract_inverted_index.134 | 80 |
| abstract_inverted_index.88% | 104 |
| abstract_inverted_index.90% | 179 |
| abstract_inverted_index.BC, | 267 |
| abstract_inverted_index.BC. | 310 |
| abstract_inverted_index.GC, | 121 |
| abstract_inverted_index.GT, | 125, 137, 271 |
| abstract_inverted_index.The | 67 |
| abstract_inverted_index.age | 192 |
| abstract_inverted_index.and | 37, 41, 59, 109, 148, 198, 202, 225, 243, 256, 291, 299, 321, 334 |
| abstract_inverted_index.eBC | 326 |
| abstract_inverted_index.for | 45, 103, 136, 141, 185, 187, 208, 215, 233, 270, 274, 284, 313, 323, 338 |
| abstract_inverted_index.not | 163 |
| abstract_inverted_index.the | 2, 10, 92, 106, 306 |
| abstract_inverted_index.was | 72, 101 |
| abstract_inverted_index.who | 161 |
| abstract_inverted_index.(BC) | 132 |
| abstract_inverted_index.(GC) | 36 |
| abstract_inverted_index.100% | 116 |
| abstract_inverted_index.BRCA | 146, 153, 186, 232, 263 |
| abstract_inverted_index.HER2 | 46, 324 |
| abstract_inverted_index.Over | 178 |
| abstract_inverted_index.Risk | 311 |
| abstract_inverted_index.TNBC | 188, 276 |
| abstract_inverted_index.This | 27 |
| abstract_inverted_index.age, | 280 |
| abstract_inverted_index.eBC. | 48 |
| abstract_inverted_index.gaps | 32, 238 |
| abstract_inverted_index.help | 331 |
| abstract_inverted_index.high | 74, 174 |
| abstract_inverted_index.risk | 43, 175, 218, 234, 288 |
| abstract_inverted_index.size | 201 |
| abstract_inverted_index.this | 96 |
| abstract_inverted_index.time | 135, 269 |
| abstract_inverted_index.with | 111, 143, 151, 228, 252, 262 |
| abstract_inverted_index.(GT), | 40 |
| abstract_inverted_index.HCPs. | 296 |
| abstract_inverted_index.These | 328 |
| abstract_inverted_index.after | 168 |
| abstract_inverted_index.blood | 258 |
| abstract_inverted_index.early | 23, 155, 275 |
| abstract_inverted_index.first | 127, 307 |
| abstract_inverted_index.human | 16 |
| abstract_inverted_index.ideal | 134, 268 |
| abstract_inverted_index.level | 68 |
| abstract_inverted_index.nodal | 203 |
| abstract_inverted_index.panel | 52 |
| abstract_inverted_index.there | 5 |
| abstract_inverted_index.tools | 220 |
| abstract_inverted_index.using | 216 |
| abstract_inverted_index.would | 330 |
| abstract_inverted_index.(HCPs) | 83 |
| abstract_inverted_index.(TNBC) | 159 |
| abstract_inverted_index.(eBC). | 26 |
| abstract_inverted_index.Delphi | 29 |
| abstract_inverted_index.access | 337 |
| abstract_inverted_index.before | 124 |
| abstract_inverted_index.breast | 24, 60, 130, 157 |
| abstract_inverted_index.cancer | 25, 61, 85, 131, 158, 209 |
| abstract_inverted_index.expert | 51 |
| abstract_inverted_index.factor | 19 |
| abstract_inverted_index.family | 196 |
| abstract_inverted_index.growth | 18 |
| abstract_inverted_index.mutant | 154 |
| abstract_inverted_index.reflex | 139 |
| abstract_inverted_index.should | 302, 316 |
| abstract_inverted_index.status | 204 |
| abstract_inverted_index.survey | 78 |
| abstract_inverted_index.tools, | 290 |
| abstract_inverted_index.tumour | 200 |
| abstract_inverted_index.(29/33) | 108 |
| abstract_inverted_index.(breast | 84 |
| abstract_inverted_index.80%-90% | 213 |
| abstract_inverted_index.Experts | 114, 211 |
| abstract_inverted_index.Methods | 49 |
| abstract_inverted_index.Results | 98 |
| abstract_inverted_index.achieve | 164 |
| abstract_inverted_index.aligned | 110 |
| abstract_inverted_index.arrived | 63 |
| abstract_inverted_index.between | 240 |
| abstract_inverted_index.consent | 123 |
| abstract_inverted_index.disease | 314 |
| abstract_inverted_index.existed | 239 |
| abstract_inverted_index.experts | 181 |
| abstract_inverted_index.factors | 207 |
| abstract_inverted_index.genetic | 34, 38, 217 |
| abstract_inverted_index.history | 197 |
| abstract_inverted_index.improve | 335 |
| abstract_inverted_index.medical | 56 |
| abstract_inverted_index.pretest | 120, 248, 300 |
| abstract_inverted_index.reached | 102, 115, 212 |
| abstract_inverted_index.region, | 4 |
| abstract_inverted_index.region. | 97 |
| abstract_inverted_index.systems | 224 |
| abstract_inverted_index.testing | 39, 140 |
| abstract_inverted_index.through | 294 |
| abstract_inverted_index.variant | 266 |
| abstract_inverted_index.≥75%. | 76 |
| abstract_inverted_index.clinical | 42, 339 |
| abstract_inverted_index.complete | 166 |
| abstract_inverted_index.explored | 91 |
| abstract_inverted_index.explores | 31 |
| abstract_inverted_index.germline | 145, 152, 183, 264 |
| abstract_inverted_index.involved | 13 |
| abstract_inverted_index.managing | 15 |
| abstract_inverted_index.modified | 28 |
| abstract_inverted_index.offering | 119, 138, 247, 281 |
| abstract_inverted_index.patients | 142, 150, 160, 189, 227, 251, 261, 277 |
| abstract_inverted_index.positive | 285 |
| abstract_inverted_index.receptor | 20 |
| abstract_inverted_index.response | 167 |
| abstract_inverted_index.results, | 286 |
| abstract_inverted_index.surgeons | 62 |
| abstract_inverted_index.surgery. | 236 |
| abstract_inverted_index.variant, | 147 |
| abstract_inverted_index.variants | 230 |
| abstract_inverted_index.-negative | 47, 325 |
| abstract_inverted_index.consensus | 30, 71, 100, 117, 214 |
| abstract_inverted_index.diagnosis | 128, 194, 308, 320 |
| abstract_inverted_index.epidermal | 17 |
| abstract_inverted_index.molecular | 89 |
| abstract_inverted_index.obtaining | 122 |
| abstract_inverted_index.patients. | 327 |
| abstract_inverted_index.performed | 318 |
| abstract_inverted_index.post-test | 282 |
| abstract_inverted_index.practical | 11 |
| abstract_inverted_index.practices | 94, 242 |
| abstract_inverted_index.reduction | 235 |
| abstract_inverted_index.relatives | 259 |
| abstract_inverted_index.statement | 70 |
| abstract_inverted_index.supported | 182 |
| abstract_inverted_index.surgeons, | 86 |
| abstract_inverted_index.suspected | 253 |
| abstract_inverted_index.treatment | 170 |
| abstract_inverted_index.utilising | 287 |
| abstract_inverted_index.Conclusion | 297 |
| abstract_inverted_index.assessment | 44, 219, 289, 312 |
| abstract_inverted_index.challenges | 12 |
| abstract_inverted_index.considered | 73 |
| abstract_inverted_index.contention | 8 |
| abstract_inverted_index.decisions. | 340 |
| abstract_inverted_index.healthcare | 81, 223 |
| abstract_inverted_index.hereditary | 254 |
| abstract_inverted_index.increasing | 7 |
| abstract_inverted_index.pathogenic | 265 |
| abstract_inverted_index.prognostic | 206 |
| abstract_inverted_index.real-world | 93, 241 |
| abstract_inverted_index.recurrence | 315 |
| abstract_inverted_index.statements | 107 |
| abstract_inverted_index.Significant | 237 |
| abstract_inverted_index.considering | 126, 149, 226, 272 |
| abstract_inverted_index.counselling | 35 |
| abstract_inverted_index.guidelines. | 113 |
| abstract_inverted_index.neoadjuvant | 169 |
| abstract_inverted_index.prioritised | 199 |
| abstract_inverted_index.recurrence. | 177, 210 |
| abstract_inverted_index.standardise | 332 |
| abstract_inverted_index.statements. | 66 |
| abstract_inverted_index.Asia-Pacific | 3, 55 |
| abstract_inverted_index.Introduction | 0 |
| abstract_inverted_index.geneticists, | 58, 87 |
| abstract_inverted_index.irrespective | 190, 278 |
| abstract_inverted_index.mainstreamed | 304 |
| abstract_inverted_index.oncologists, | 57, 88 |
| abstract_inverted_index.particularly | 245 |
| abstract_inverted_index.pathological | 165 |
| abstract_inverted_index.post-surgery | 322 |
| abstract_inverted_index.streamlining | 292 |
| abstract_inverted_index.international | 112 |
| abstract_inverted_index.practitioners | 82 |
| abstract_inverted_index.non-geneticist | 295 |
| abstract_inverted_index.(HER2)-negative | 22 |
| abstract_inverted_index.recommendations | 329 |
| abstract_inverted_index.triple-negative | 156 |
| abstract_inverted_index.recommendations, | 244 |
| abstract_inverted_index.likely/pathogenic | 144, 229 |
| abstract_inverted_index.low/under-resourced | 222 |
| abstract_inverted_index.biologists/pathologists) | 90 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5033700679 |
| countries_distinct_count | 11 |
| institutions_distinct_count | 16 |
| corresponding_institution_ids | https://openalex.org/I4210103786 |
| citation_normalized_percentile.value | 0.31355328 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |